CN Patent

CN101715448B — 一种咪唑-5-羧酸衍生物的治疗用途

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2013-06-19 · 13y expired

What this patent protects

本发明公开了2-丁基-4-氯-1-[2’-(1H-四唑-5-基)1，1’-联苯基-甲基]咪唑-5-羧酸，1-[(异丙氧基)羰氧基]甲基酯及其药学上可接受的盐在制备治疗高血压引起的靶器官损伤的药物中的应用，尤其公开了该化合物在制备治疗高血压引起的左心室肥厚、肾功能损害、主动脉增厚的药物中的应用，从而为高血压病人提供一种治疗靶器官损伤的有效药物和方法。

USPTO Abstract

本发明公开了2-丁基-4-氯-1-[2’-(1H-四唑-5-基)1，1’-联苯基-甲基]咪唑-5-羧酸，1-[(异丙氧基)羰氧基]甲基酯及其药学上可接受的盐在制备治疗高血压引起的靶器官损伤的药物中的应用，尤其公开了该化合物在制备治疗高血压引起的左心室肥厚、肾功能损害、主动脉增厚的药物中的应用，从而为高血压病人提供一种治疗靶器官损伤的有效药物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101715448B
Jurisdiction
CN
Classification
—
Expires
2013-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Salubris Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.